Based on genetic studies reporting loss-of-function SCN5A mutations in ERS and basic science studies demonstrating more prominent AP notching and J waves following INa blockade, ajmaline would be predicted to accentuate J waves in ERS patients. The gene discussed is SCN5A; the disease is amelogenesis imperfecta type 1G.